/XPH
XPH Stock - SPDR S&P Pharmaceuticals ETF
Financial Services|Asset ManagementAMEX
$57.07+1.53%
+$0.86 (+1.53%) • Dec 22
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.96
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.82
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $62.78
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for XPH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$56.50 – $57.64
TARGET (TP)$65.63
STOP LOSS$52.50
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.94
52W High$57.24
52W Low$35.22
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
XPHLoading earnings data...
Latest News
Senior Administration Official Says Companies Agree To Sell All Future Drugs At Most Favored Nation Prices; Portion Of Revenues From Foreign Sales Will Be Remitted To U.S. To Offset Costs For Americans; Companies Will Get Relief From U.S. Tariffs In Exchange;14 Of 17 Leading Drug Manufacturers Now Part Of Trump Administration's Most Favored Nation Initiative; Several Manufacturers Agree To Donate Active Pharmaceutical Ingredients To U.S. Strategic Reserve
📈 PositiveBenzinga•Dec 19, 2025, 07:21 PM
Reuters: US And UK To Agree To Zero Tariffs On Pharmaceuticals, Announcement Expected At White House Today
📈 PositiveBenzinga•Dec 1, 2025, 12:05 PM
U.S Trade Rep Greer Says Trump's Pharmaceutical Tariff Aimed At Ensuring That Most Innovative Drugs Are Produced In The U.S.; We're Always Going To Trade With China, Need To Find A Place Where Both Are Comfortable; China's Reliance On Exports Is Not Sustainable; I Want To Get To A Place Where Trade With China Is More Balanced; China 'Wolf Warrior' Ethos Has Leaked Into U.S.-China Economic Relations; China Negotiations Have A More Political Edge To Them; Average Tariff Of 55% On Chinese Imports Is Status Quo
➖ NeutralBenzinga•Oct 8, 2025, 03:03 PM
U.S. Trade Representative Jamieson Greer Says Trump's Pharmaceutical Tariff Aimed At Ensuring That Most Innovative Drugs Are Produced In The U.S.; We're Always Going To Trade With China, Need To Find A Place Where Both Countries Are Comfortable; China's Reliance On Exports Is Not Sustainable; I Want To Get To A Place Where Trade With China Is More Balanced
➖ NeutralBenzinga•Sep 30, 2025, 04:19 PM
Benzinga Market Summary: S&P Rises Ahead Of Close, PCE Inflation Comes In Line with Estimates, Trump Announces Tariffs Which Include Pharmaceuticals, Furniture And Trucks; Intel Rises On Proposed 1:1 Domestic-To-Imported Chip Ratio Requirement
➖ NeutralBenzinga•Sep 26, 2025, 07:53 PM•Also:
Britain Would Face 100% Tariff On Pharmaceuticals Under Latest Trump Plan, Sources Say
📉 NegativeBenzinga•Sep 26, 2025, 06:31 PM
White House Says Latest Pharmaceuticals Tariffs Don't Apply To Countries With Negotiated Trade Deals
📈 PositiveBenzinga•Sep 26, 2025, 04:46 PM
Benzinga Market Summary: S&P Flat, PCE Inflation Comes In Line with Estimates, Trump Announces Tariffs Which Include Pharmaceuticals, Furniture And Trucks; Intel Rises On Proposed 1:1 Domestic-To-Imported Chip Ratio Requirement
➖ NeutralBenzinga•Sep 26, 2025, 03:15 PM•Also: , ,
Frequently Asked Questions about XPH
What is XPH's current stock price?
SPDR S&P Pharmaceuticals ETF (XPH) is currently trading at $57.07 per share. The stock has moved +1.53% today.
What is the analyst price target for XPH?
No analyst price targets are currently available for this stock.
What sector is SPDR S&P Pharmaceuticals ETF in?
SPDR S&P Pharmaceuticals ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the AMEX exchange.
What is XPH's market cap?
SPDR S&P Pharmaceuticals ETF has a market capitalization of $0.21 billion, making it a small-cap company.
Does XPH pay dividends?
No, SPDR S&P Pharmaceuticals ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBFOR
ALPS Barron's 400 ETF
$84.41
Mkt Cap: $0.2B
DEUS
Xtrackers Russell US Multifactor ETF
$58.91
Mkt Cap: $0.2B
DFE
WisdomTree Europe SmallCap Dividend Fund
$71.52
Mkt Cap: $0.2B
HSCZ
iShares Currency Hedged MSCI EAFE Small-Cap ETF
$39.45
Mkt Cap: $0.2B
SDG
iShares MSCI Global Impact ETF
$84.37
Mkt Cap: $0.2B
TBG
TBG Dividend Focus ETF
$33.94
Mkt Cap: $0.2B
TUR
iShares MSCI Turkey ETF
$34.50
Mkt Cap: $0.2B
XES
SPDR S&P Oil & Gas Equipment & Services ETF
$81.87
Mkt Cap: $0.2B
XTL
SPDR S&P Telecom ETF
$156.19
Mkt Cap: $0.2B
XTN
SPDR S&P Transportation ETF
$94.07
Mkt Cap: $0.1B
Explore stocks similar to XPH for comparison